We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
Cap. Flow
+$2.92B
Cap. Flow %
6.68%
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$408M
2
NVDA icon
NVIDIA
NVDA
+$395M
3
MSFT icon
Microsoft
MSFT
+$382M
4
AMZN icon
Amazon
AMZN
+$253M
5
PLTR icon
Palantir
PLTR
+$148M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Consumer Discretionary 10.78%
3 Consumer Staples 10.15%
4 Industrials 10.05%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEC icon
1751
Orion
OEC
$394M
$256K ﹤0.01%
16,214
+5,335
+49% +$90.1K
WEAV icon
1752
Weave Communications
WEAV
$491M
$256K ﹤0.01%
+16,081
New +$226K
GXO icon
1753
GXO Logistics
GXO
$6.06B
$255K ﹤0.01%
5,856
+19
+0.3% +$1.05K
BY icon
1754
Byline Bancorp
BY
$1.75B
$254K ﹤0.01%
+8,769
New +$254K
VTOL icon
1755
Bristow Group
VTOL
$1.35B
$254K ﹤0.01%
+7,407
New +$262K
AVBP icon
1756
ArriVent BioPharma
AVBP
$1.48B
$254K ﹤0.01%
+9,532
New +$274K
PDFS icon
1757
PDF Solutions
PDFS
$2.13B
$254K ﹤0.01%
9,377
+2,887
+44% +$87K
POST icon
1758
Post Holdings
POST
$4.12B
$254K ﹤0.01%
2,215
+152
+7% +$17.3K
KNSA icon
1759
Kiniksa Pharmaceuticals
KNSA
$4.83B
$253K ﹤0.01%
12,807
+3,357
+36% +$76.6K
JHG
1760
DELISTED
Janus Henderson
JHG
$253K ﹤0.01%
5,952
+398
+7% +$16.9K
REPL icon
1761
Replimune Group
REPL
$814M
$252K ﹤0.01%
20,788
+5,247
+34% +$63.8K
NEXT icon
1762
NextDecade
NEXT
$1.85B
$251K ﹤0.01%
32,562
-11,134
-25% -$71.3K
DAR icon
1763
Darling Ingredients
DAR
$9.93B
$251K ﹤0.01%
7,441
+509
+7% +$19.2K
ECVT icon
1764
Ecovyst
ECVT
$1.36B
$250K ﹤0.01%
32,773
+10,783
+49% +$79.7K
PLRX icon
1765
Pliant Therapeutics
PLRX
$67.5M
$249K ﹤0.01%
18,931
+4,570
+32% +$62.4K
CECO icon
1766
Ceco Environmental
CECO
$4.42B
$249K ﹤0.01%
+8,232
New +$234K
FNB icon
1767
FNB Corp
FNB
$6.78B
$249K ﹤0.01%
16,824
+1,150
+7% +$17.6K
VIR icon
1768
Vir Biotechnology
VIR
$1.47B
$246K ﹤0.01%
33,563
+6,767
+25% +$53.4K
LMB icon
1769
Limbach Holdings
LMB
$867M
$246K ﹤0.01%
+2,877
New +$254K
DAWN
1770
DELISTED
Day One Biopharmaceuticals
DAWN
$246K ﹤0.01%
19,394
+3,687
+23% +$51.3K
PL icon
1771
Planet Labs
PL
$7.3B
$246K ﹤0.01%
60,777
+20,426
+51% +$63.4K
GAP
1772
The Gap Inc
GAP
$6.84B
$245K ﹤0.01%
10,387
+741
+8% +$16.9K
CLB icon
1773
Core Laboratories
CLB
$538M
$245K ﹤0.01%
+14,152
New +$273K
MFIC icon
1774
MidCap Financial Investment
MFIC
$784M
$245K ﹤0.01%
18,141
+7,062
+64% +$95.9K
EYE icon
1775
National Vision
EYE
$1.6B
$245K ﹤0.01%
23,480
+7,221
+44% +$79K

Similar funds

ProShare Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.

  • ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
  • ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
  • ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
  • ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
  • ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
  • ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
  • ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.